ENGAGE-PD: Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
Trial ID: NCT05022147
Interventional - Phase 1 - Active, not recruiting
The purpose of this study is to assess how alternating-frequency Deep Brain Stimulation (DBS) works to improve postural instability and gait, while also treating other motor symptoms of Parkinson Disease (PD).
Conditions
- Parkinson Disease
- Gait Disorders, Neurologic
- Disease Progression
- Subthalamic Nucleus
- Accidental Fall
- Deep Brain Stimulation
Interventions
- High-Frequency-Only Stimulation
- Low-Frequency-Only Stimulation
- Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation
- Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation
- Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation
- Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation
- OFF Dopaminergic Medication
- ON Dopaminergic Medication
Eligibility
Inclusion criteria
- Bilateral STN DBS for PD
- Medtronic Percept PC implanted DBS battery/pulse generator/recording system
- Presence of balance and/or walking impairment and/or freezing of gait
- Can walk without assistance, OFF meds, based on yes/no verbal response
Exclusion criteria
- Severity of gait impairment should not require dependency to walker or cane
- Cannot tolerate monopolar stimulation at either of the two middle electrode contacts (prerequisite for the recording mode of the DBS) at high frequency (130 Hz) or low frequency (60 Hz).
- Concomitant conditions that may affect significantly the evaluation of balance or gait, including orthopedic, rheumatologic or other neurological diseases
- Contraindication to physical therapy
- Age \< 21
- Diagnosis of dementia
- Not agreeable to having video taken of entire research visit
Sponsor
James Liao
Source: ClinicalTrials.gov
Search more clinical trials on myTomorrows